pentoxifylline has been researched along with Besnier-Boeck Disease in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present the case of a patient with sarcoidosis corticodependent despite the use of azathioprine." | 7.88 | [The pentoxifylline, a corticosteroid sparing in the treatment of sarcoidosis: A case report]. ( Diallo, BD; Diot, B; Diot, P; Flament, T; Marchand-Adam, S; Plantier, L; Sow, OY, 2018) |
| "The widely accepted standard therapy for cutaneous sarcoidosis includes corticosteroids, antimalarials, and methotrexate." | 4.84 | Cutaneous sarcoidosis therapy updated. ( Badgwell, C; Rosen, T, 2007) |
| "We present the case of a patient with sarcoidosis corticodependent despite the use of azathioprine." | 3.88 | [The pentoxifylline, a corticosteroid sparing in the treatment of sarcoidosis: A case report]. ( Diallo, BD; Diot, B; Diot, P; Flament, T; Marchand-Adam, S; Plantier, L; Sow, OY, 2018) |
| "Pentoxifylline (PTX) is a methylxanthine derivative with a variety of anti-inflammatory effects." | 2.44 | Pentoxifylline: a drug with wide spectrum applications in dermatology. ( Zargari, O, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diallo, BD | 1 |
| Diot, B | 1 |
| Flament, T | 1 |
| Plantier, L | 1 |
| Diot, P | 1 |
| Sow, OY | 1 |
| Marchand-Adam, S | 1 |
| Zargari, O | 1 |
| Antoniu, SA | 1 |
| Moller, DR | 1 |
| Badgwell, C | 1 |
| Rosen, T | 1 |
| Körber, M | 1 |
| Kamp, S | 1 |
| Kothe, H | 1 |
| Braun, J | 1 |
| Dalhoff, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata: a Clinical and Dermoscopic Study.[NCT06087796] | Phase 1 | 60 participants (Anticipated) | Interventional | 2023-10-31 | Not yet recruiting | ||
| Clinical Biomarkers of Disease Activity and Treatment Responses in Patients With CNS Sarcoidosis Treated With H.P. Acthar Gel[NCT02298491] | Phase 4 | 4 participants (Actual) | Interventional | 2016-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Total number of lesions assessed at 1 year (NCT02298491)
Timeframe: 1 year
| Intervention | lesions (Number) |
|---|---|
| H.P. Acthar Gel | 5 |
4 reviews available for pentoxifylline and Besnier-Boeck Disease
| Article | Year |
|---|---|
Pentoxifylline: a drug with wide spectrum applications in dermatology.
Topics: Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Behcet Syndrome; C | 2008 |
Targeting the TNF-alpha pathway in sarcoidosis.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Eta | 2010 |
Treatment of sarcoidosis -- from a basic science point of view.
Topics: Etanercept; Granuloma; Humans; Immunoglobulin G; Immunosuppressive Agents; Interleukins; Pentoxifyll | 2003 |
Cutaneous sarcoidosis therapy updated.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Allopurinol; Animals; Anti-Inflammatory Agents | 2007 |
2 other studies available for pentoxifylline and Besnier-Boeck Disease
| Article | Year |
|---|---|
[The pentoxifylline, a corticosteroid sparing in the treatment of sarcoidosis: A case report].
Topics: Azathioprine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Middle Aged; Pentoxifylline | 2018 |
[Pentoxifylline inhibits secretion of O2- and TNF-alpha by alveolar macrophages in patients with sarcoidosis].
Topics: Adult; Female; Humans; In Vitro Techniques; Macrophages, Alveolar; Male; Pentoxifylline; Respiratory | 1995 |